Nadine Schroeder nackt sorted by
relevance

Admin25.08.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Find Nadine Schroeder in the United States We found 12 entries for Nadine Schroeder in the United States.
2401
Admin21.08.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Baker 1, Majid Ghoddusi 1 1 Five Prime Therapeutics, Inc.
5603
Admin03.08.2021

Council

West Huron Care Centre BWRH :• , Buffalo, NY, USA Tumor microenvironment Biomarkers Checkpoint blockade Immune monitoring Gene expression Solid tumors T cell Tumor infiltrating lymphocytes TILs P17 The immune-excluded phenotype beyond colorectal cancer Carl Morrison 1, Sean Glenn 1, Wiam Bshara 2, Sarabjot Pabla 1, Blake Burgher 1, Vincent Giamo 1, Jonathan Andreas 1, Mary Nesline 1, Mark Gardner 1, Antonios Papanicolau-Sengos 1, Igor Puzanov 2, Marc Ernstoff 2, Jeffrey Conroy 1 1 OmniSeq, Inc.
5505
Admin15.08.2021

Find Nadine Schroeder's Background Report in the US

Mallon 1, Christophe Poulet 1, Amanda Enstrom 1, Somayeh Honarmand 1, Aimee L.
6306
Admin19.09.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Fox 3, Barbara Seliger 2 1 Ludwig Maximilian University, Munich, Germany 2Martin Luther University, Halle, Germany 3Robert W.
601
Admin27.07.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

, Kenilworth, NJ, USA Biomarkers Checkpoint blockade Gene expression Solid tumors Tumor microenvironment P20 Distinct tumour immune profiles in non-small cell lung cancer NSCLC revealed by automated quantitative digital image analyses of immune biomarker densities and spatial relationships Marie Cumberbatch 1, Elaine Foster 2, James Clay 2, Sunita Mistry 2, Andrew Lawrence 2, Christopher Womack 2, David Fairley 2 1 Immune Insight Limited, Macclesfield, United Kingdom 2HistologiX Limited, Nottingham, United Kingdom Immune contexture Tumor microenvironment Biomarkers Immune monitoring Tumor infiltrating lymphocytes TILs P21 Correlation of inflammatory biomarkers and patient-reported outcomes in patients with urothelial carcinoma treated with durvalumab Arnold Degboe 1, Srikala Sridhar 2, Jingsong Zhang 3, Pralay Mukhopadhyay 1, Ashok Gupta 1, Lorin Roskos 1, Xiang Guo 1, Terence Friedlander 4 1 AstraZeneca, Gaithersburg, MD, USA 2Princess Margaret Cancer Centre, Toronto, ON, Canada 3Moffitt Cancer Center, 12902 USF Magnolia Drive, FL, USA 4UCSF Medical Center, San Francisco, CA, USA Biomarkers Inflammation Solid tumors Clinical study P22 Up-regulation of a T and NK cell gene signature in peripheral blood is associated with mRNA-based immunotherapy in lung and prostate cancer.
7200
Admin14.08.2021

SITC 2017 Abstract Titles

Congregational Contact — Christa Ihrig AD HOC MINISTRY CATEGORY• , Kenilworth, NJ, USA 7Syndax Pharmaceuticals, Inc.
Admin20.09.2021

Council

, Santa Clara, CA, USA T cell Gene expression Targeted therapy Systems biology Proteomics Immune monitoring Biomarkers Regulatory T cell Treg P41 IgG antibodies correspond with T cell responses to tumor neoantigens Tyler Hulett 1, Shawn Jensen 1, Larry David 2, Ashok Reddy 2, Phillip Wilmarth 2, Carmen Ballesteros-Merino 1, Christopher Dubay 1, Michael Afentoulis 1, Bernard Fox 1 1 Earle A.
1905
Admin21.08.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Links are provided for reference only and MyLife.
Admin24.08.2021

Council

Personal reviews and more You'll also get alerts when info changes.
3703
Admin09.08.2021

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Council Recording Secretar y — Laurie Erb• Kaufmann 1, Judy Jacques 1, Christine McCoy 1, Michael O'Keeffe 1, Crystal Cabral 1, Yana Ostrovsky 1, Ning Wu 1, Jason Dobston 1, Theresa Zhang 1, Pamela Carroll 1, Jessica Flechtner 1, Wendy Broom 1 1 Genocea Biosciences, Inc.
5303